Learn more about our Legal work.
The Federal Trade Commission published a proposed rule in the Federal Register that would, among other things, prohibit employers from imposing non-compete agreements on their employees.
AdvaMed, The Medtech Association®, asked the Supreme Court to affirm the judgments of the court of appeals in the Seventh Circuit in a significant case concerning the False Claims Act…
AdvaMed® responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
The Advanced Medical Technology Association® (AdvaMed®) asked the U.S. Supreme Court to review and reverse a California appeals court’s decision imposing over $300 million in penalties on a medical device…
The Advanced Medical Technology Association® (AdvaMed®) has asked the U.S. Supreme Court to affirm a Third Circuit decision that confirms the government’s right to dismiss qui tam suits under the…
AdvaMed® urged California’s First District Court of Appeal to overturn an erroneous decision by the trial court that has the potential to impose unfair and unwarranted liability upon companies that…
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed® developed tools and resources to…
Pat Fogarty sat down with industry observer Jack Kalavritinos for a Q&A to discuss the current landscape of litigation in the medical device industry.
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
AdvaMed® publishes a quarterly attorney ad spend tracker, which highlights the amount of money spent on medical device mass tort television advertising.